Continuous Glucose Monitoring (CGM): Technologies and Global Markets
Description
Continuous Glucose Monitoring (CGM): Technologies and Global Markets
Report Scope:
The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.
Report Includes:
27 data tables and 28 additional tables
A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies
Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments
Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region
Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.
Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
Review of the key patent grants and patent applications within select CGM technologies
Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.
Companies Mentioned
ABBOTT LABORATORIES
ASCENSIA DIABETES CARE HOLDINGS AG
Beta Bionics, Inc.
BIGFOOT BIOMEDICAL
DEXCOM INC.
EMPERRA GMBH E-HEALTH TECHNOLOGIES
F. HOFFMANN-LA ROCHE LTD.
Glucotrack, Inc.
INSULET CORP.
INTUITY MEDICAL INC.
LifeScan IP Holdings, LLC
MEDTRONIC PLC
NEMAURA MEDICAL INC.
NOVIOSENSE BV
NOVO NORDISK A/S
PKVITALITY
Qlibrium
SANOFI S.A.
SENSEONICS HOLDINGS INC.
SINOCARE INC.
TANDEM DIABETES CARE
YPSOMED AG
Report Scope:
The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.
Report Includes:
27 data tables and 28 additional tables
A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies
Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments
Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region
Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.
Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
Review of the key patent grants and patent applications within select CGM technologies
Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.
Companies Mentioned
ABBOTT LABORATORIES
ASCENSIA DIABETES CARE HOLDINGS AG
Beta Bionics, Inc.
BIGFOOT BIOMEDICAL
DEXCOM INC.
EMPERRA GMBH E-HEALTH TECHNOLOGIES
F. HOFFMANN-LA ROCHE LTD.
Glucotrack, Inc.
INSULET CORP.
INTUITY MEDICAL INC.
LifeScan IP Holdings, LLC
MEDTRONIC PLC
NEMAURA MEDICAL INC.
NOVIOSENSE BV
NOVO NORDISK A/S
PKVITALITY
Qlibrium
SANOFI S.A.
SENSEONICS HOLDINGS INC.
SINOCARE INC.
TANDEM DIABETES CARE
YPSOMED AG
Table of Contents
123 Pages
- Chapter 1 Introduction
- 1.2 Study Goals and Objectives
- 1.3 Reasons for Doing This Study
- 1.4 Scope of Report
- 1.5 What's New in This Update?
- 1.6 Information Sources
- 1.7 Research Methodology
- 1.8 Geographic Breakdown
- 1.9 Analyst's Credentials
- 1.10 BCC Custom Research
- 1.11 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- 2.1 Highlights of the Market for CGM Devices
- Chapter 3 Market and Technology Background
- 3.1 Diabetes
- 3.1.1 Types of Diabetes Mellitus
- 3.1.2 Diabetes Diagnosis
- 3.1.3 Diabetes Prevalence and Global Economic Burden
- 3.1.4 Treatment of Diabetes
- 3.1.5 Importance of Glucose Monitoring in Diabetes
- 3.1.6 SMBG Devices
- 3.1.7 Noninvasive Blood Glucose Monitoring
- 3.1.8 Continuous Glucose Monitoring (CGM)
- 3.1.9 Working to Improve CGM Technology
- Chapter 4 Market Breakdown by Technology Type
- 4.1 Global Market for Continuous Glucose Monitoring (CGM) Devices
- 4.2 Global CGM Markets
- 4.3 Global Smart Insulin Pumps and Pens Markets
- 4.4 Global SMBG Meters and Test Strips Markets
- Chapter 5 Market Breakdown by End-User Settings
- 5.1 CGM Market, by End-User Settings
- 5.2 CGM Market for Home Use
- 5.3 Hospital and Clinics
- 5.4 Others
- Chapter 6 CGM Market by Type of Diabetes
- 6.1 CGM Markets, by Type of Diabetes
- 6.2 Type 1 Diabetes
- 6.3 Type 2 Diabetes
- 6.4 Gestational Diabetes
- 6.5 Others
- Chapter 7 CGM Markets, by User's Age
- 7.1 CGM Markets, by User's Age
- 7.2 Children
- 7.3 Teenagers
- 7.4 Youth
- 7.5 Middle-Aged
- 7.6 Aged
- Chapter 8 Market Breakdown by Region
- 8.1 North America
- 8.1.1 U.S
- 8.1.2 Canada
- 8.2 Europe
- 8.2.1 Germany
- 8.2.2 The UK
- 8.2.3 France
- 8.2.4 Italy
- 8.2.5 Rest of Europe
- 8.3 Asia-Pacific
- 8.3.1 China
- 8.3.2 Japan
- 8.3.3 South Korea
- 8.3.4 Rest of Asia-Pacific
- 8.4 Rest of the World
- Chapter 9 Patent Review
- 9.1 Patent Review
- Chapter 10 Competitive Landscape
- 10.1 Market Share Analysis
- Chapter 11 COVID-19 Impact on the CGM Market
- 11.1 COVID-19 Impact on the CGM Market
- Chapter 12 Analysis of the Market Opportunities
- Chapter 13 Company Profiles
- 13.1 Major Companies
- ABBOTT LABORATORIES
- BETA BIONICS, INC.
- BIGFOOT BIOMEDICAL
- DEXCOM INC.
- F. HOFFMANN-LA ROCHE LTD.
- INSULET CORP.
- LIFESCAN IP HOLDINGS, LLC
- MEDTRONIC PLC
- NOVO NORDISK A/S
- PKVITALITY
- SANOFI S.A.
- SENSEONICS HOLDINGS INC.
- TANDEM DIABETES CARE
- YPSOMED AG
- 13.2 Other Companies
- ASCENSIA DIABETES CARE HOLDINGS AG
- EMPERRA GMBH E-HEALTH TECHNOLOGIES
- GLUCOTRACK, INC.
- INTUITY MEDICAL INC.
- NEMAURA MEDICAL INC.
- NOVIOSENSE BV
- QLIBRIUM
- SINOCARE INC.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
